Volibo M 0.3/500 mg
| SKU | 2604 |
|---|---|
| Generic For | Voglibose M |
| Manufacturer | Sun Pharmaceuticals Ltd |
| Active Ingredient | Voglibose/Metformin Hcl |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Tablet/s | US$ 0.84 | US$ 25.20 | |||
|
|||||
| 60 Tablet/s | US$ 0.63 | US$ 38.0025%US$ 50.40 | |||
|
|||||
| 90 Tablet/s | US$ 0.63 | US$ 57.0025%US$ 75.60 | |||
|
|||||
Volibo M 0.3/500 mg – Affordable Voglibose M Alternative
Volibo M 0.3/500 mg is used to control high blood sugar, along with a proper diet and exercise program. It is effective for people with type 2 diabetes. Controlling high blood sugar levels helps prevent complications associated with diabetes, including kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Adequate control of diabetes may also lessen the risk of heart complications such as heart attack or stroke.
Volibo M 0.3/500 mg is a combination of Voglibose and Metformin, which stimulates the body to release more insulin (a hormone that allows the body to use sugar (glucose) from the diet properly.
Precautions of Volibo M 0.3/500 mg
Always take Volibo M 0.3/500 mg according to the doctor’s instructions. Depending on your response to the treatment, the doctor alters your dose. Your dose may increase or decrease depending on your condition. You should check with your doctor if you are not sure. Volibo M should not be given to patients with known hypersensitivity to Voglibose, Metformin, or other inactive constituents.
Patients suffering from inflammatory bowel syndrome, diabetic ketoacidosis, colonic ulcerations, partial intestinal obstruction, and chronic disorders should brief their condition to their doctor before taking this medicine. The antidiabetic drug should be given with caution when used along with other antidiabetic agents such as biguanide, sulfonyl amide, sulfonylurea, and insulin preparations for improving insulin resistance.
Side effects of Volibo M 0.3/500 mg
Research studies have shown that Volibo M 0.3/500 mg helps to control blood sugar in patients with type 2 Diabetes Mellitus. The most common side effects of Volibo M 0.3/500 are given below:
- Gastrointestinal tract - flatulence, bloating, abdominal pain, diarrhoea, abdominal fullness, and nausea
- Liver problems - hepatitis with severe cholestasis
- Central nervous system disorders - vomiting, nausea, and dizziness.
Tell your physician about your medical history, current physical status, and the medicines you have been using. This helps your physician determine the best treatment for you.
How to use Volibo M 0.3/500 mg
The dosage of Volibo M 0.3/500 mg should be individualized based on effectiveness and tolerance. It is usually recommended two times daily for adequate blood sugar control. Follow the dosage prescribed by your doctor. The dose taken before meals has been effective and recommended by most doctors. The tablet can be taken before or after a meal or snack. Swallow the tablet without chewing, breaking, or crushing it. If you miss a dose, please consume it immediately once you remember. However, if you remember the next day, skip the missed dose and continue with your regular dosing schedule. Do not attempt to take two doses on the same day to make up for the missed one.
What is Voglibose/Metformin HCl and what condition does it treat?
Volibo M 0.3/500 mg contains two active ingredients: Voglibose and Metformin HCl. This combination antidiabetic medication is prescribed to manage type 2 diabetes mellitus in adults. Voglibose belongs to a class of drugs called alpha-glucosidase inhibitors, while Metformin is a biguanide. Together, they help control blood sugar levels by targeting different mechanisms. This dual-action diabetes medicine is particularly effective for patients whose blood glucose is not adequately controlled with diet, exercise, or single-drug therapy alone. The combination tablet offers convenient dosing for improved glycemic control.
How does Voglibose/Metformin HCl work in the body?
Volibo M 0.3/500 mg works through a complementary dual mechanism. Voglibose slows down carbohydrate digestion in the intestines by inhibiting enzymes that break down complex sugars, which prevents rapid blood glucose spikes after meals. Metformin HCl reduces glucose production in the liver, improves insulin sensitivity in muscles, and decreases sugar absorption in the gut. This two-pronged approach addresses multiple aspects of type 2 diabetes management. The combined action provides better post-meal blood sugar control while reducing fasting glucose levels, offering comprehensive glycemic management throughout the day.
How long does Volibo M 0.3/500 mg take to work?
Volibo M 0.3/500 mg begins working shortly after ingestion, with Voglibose acting on carbohydrates in your current meal to reduce post-meal glucose spikes within one to two hours. Metformin HCl starts influencing blood sugar within a few hours but reaches optimal effectiveness after several days of consistent use. Most patients notice measurable improvements in their blood glucose readings within one to two weeks. However, full therapeutic benefits for type 2 diabetes control typically develop over two to three months of regular use, as reflected in HbA1c test results that measure average blood sugar over time.
When and how should I take Volibo M 0.3/500 mg?
Take Volibo M 0.3/500 mg exactly as prescribed by your healthcare provider, typically with meals or just before eating. This timing is crucial because Voglibose works by slowing carbohydrate digestion during your meal. Swallow the tablet whole with water—do not crush or chew it. The usual dosing schedule is two to three times daily, depending on your doctor's instructions and your diabetes management needs. Taking this antidiabetic medication consistently at the same times each day helps maintain stable blood glucose control. Always follow your prescribed dose and never adjust it without medical guidance.
Is Volibo M 0.3/500 mg safe for long-term use?
Volibo M 0.3/500 mg is designed for long-term management of type 2 diabetes when used under medical supervision. Many patients take this combination antidiabetic medication for years as part of their ongoing glycemic control strategy. The safety profile of both Voglibose and Metformin HCl is well-established through extensive clinical use. Regular monitoring through blood tests, including kidney function and vitamin B12 levels, helps ensure continued safe use. Your doctor will periodically review your treatment to confirm the medication remains appropriate and effective for your diabetes management needs and overall health status.
Can I take Volibo M 0.3/500 mg with other medicines?
Volibo M 0.3/500 mg may interact with certain medications, so inform your doctor about all drugs and supplements you take. This diabetes medicine can interact with other blood sugar-lowering medications, increasing hypoglycemia risk. Certain drugs like corticosteroids, diuretics, and some blood pressure medications may affect its effectiveness. Alcohol consumption should be limited as it can increase the risk of lactic acidosis with Metformin. Contrast dyes used in imaging procedures may require temporary discontinuation. Always provide your healthcare provider with a complete medication list to ensure safe, effective use of this antidiabetic combination therapy.
How does Volibo M 0.3/500 mg compare to similar medicines in its class?
Volibo M 0.3/500 mg offers distinct advantages compared to single-agent diabetes treatments. Unlike standalone Metformin, this combination addresses both fasting and post-meal blood sugar through dual mechanisms. Compared to other alpha-glucosidase inhibitor combinations, Voglibose typically causes fewer digestive side effects than acarbose. The fixed-dose combination provides better adherence than taking separate tablets. While DPP-4 inhibitors or SGLT2 inhibitors offer alternative approaches, Volibo M 0.3/500 mg specifically targets carbohydrate metabolism and insulin resistance simultaneously. Your doctor will recommend the best antidiabetic option based on your individual glycemic patterns, tolerance, and overall health profile.
Is the generic Voglibose/Metformin HCl as effective as branded versions?
Generic Voglibose/Metformin HCl contains identical active ingredients in the same strengths as branded Volibo M 0.3/500 mg and meets stringent regulatory standards for bioequivalence. This means the generic version works the same way in your body, producing equivalent therapeutic effects for type 2 diabetes control. Regulatory authorities require generic antidiabetic medications to demonstrate they deliver the same blood levels of active ingredients as brand-name products. The primary differences lie in inactive ingredients, packaging, and cost rather than effectiveness. Many patients successfully use generic formulations for reliable, affordable diabetes management with comparable glycemic control outcomes.
Where can I buy Volibo M 0.3/500 mg online safely?
You can purchase Volibo M 0.3/500 mg safely from PremiumRxDrugs, a fully licensed pharmacy serving patients in the USA, UK, Australia, Canada, and worldwide. PremiumRxDrugs sources only authentic, manufacturer-supplied diabetes medications and offers competitive pricing on both branded and generic formulations. The pharmacy provides discreet packaging and reliable worldwide shipping, including free delivery options on qualifying orders. With secure prescription management and straightforward reordering, you can maintain consistent access to your antidiabetic medication. Trusted by customers for over a decade, PremiumRxDrugs ensures quality, authenticity, and professional service for your type 2 diabetes treatment needs.
Why do patients choose PremiumRxDrugs for Volibo M 0.3/500 mg?
Patients trust PremiumRxDrugs for Volibo M 0.3/500 mg because of guaranteed medication authenticity from verified manufacturers, ensuring effective diabetes management. The licensed pharmacy offers competitive pricing that makes long-term antidiabetic treatment more affordable without compromising quality. Convenient features like easy prescription management and simple reordering save time for ongoing therapy. Discreet, secure packaging respects your privacy, while worldwide shipping including free delivery options ensures reliable access to your medication. With more than ten years serving diabetes patients across the USA, UK, Australia, Canada, and globally, PremiumRxDrugs combines professional service, authentic medicines, and customer-focused convenience for dependable type 2 diabetes care.
What are the common side effects of Voglibose/Metformin HCl?
Common side effects of Voglibose/Metformin HCl primarily involve digestive symptoms. Voglibose often causes gas, bloating, abdominal discomfort, and diarrhea due to undigested carbohydrates fermenting in the intestines. Metformin HCl may cause nausea, stomach upset, diarrhea, and metallic taste, especially when starting treatment. These gastrointestinal effects typically decrease as your body adjusts to the medication. Taking the tablets with meals helps minimize stomach issues. Less common but serious effects include lactic acidosis (rare but requires immediate medical attention) and vitamin B12 deficiency with prolonged use. Most patients tolerate this antidiabetic combination well once adjusted.
Who should avoid taking Voglibose/Metformin HCl?
Voglibose/Metformin HCl is not suitable for everyone. Patients with type 1 diabetes, diabetic ketoacidosis, or severe kidney disease should avoid this medication. Those with liver problems, heart failure, or conditions causing poor oxygen delivery to tissues face increased lactic acidosis risk with Metformin. People with inflammatory bowel disease, intestinal obstruction, or digestive disorders may not tolerate Voglibose well. This antidiabetic combination is not recommended during pregnancy or breastfeeding. Patients with alcohol dependence or those scheduled for surgery or imaging with contrast dyes require special precautions. Your healthcare provider will evaluate your complete medical history before prescribing this diabetes treatment.
Login
Sign Up
Login
Sign Up